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FRETContradictory results have been reported with respect to the depth of penetration and the orientation of pul-
monary surfactant protein SP-B in phospholipid membranes and its relative selectivity to interact with anion-
ic over zwitterionic phospholipid species. In the present study we have re-evaluated lipid–protein
interactions of SP-B by analysing Förster resonance energy transfer (FRET) efﬁciencies, obtained from time-
resolved measurements, from the single tryptophan in SP-B to different ﬂuorescently labelled phospholipids
in matrix bilayers made of either pure phosphatidylcholine (POPC) or the full lipid extract obtained from pu-
riﬁed surfactant. In the background of POPC membranes SP-B exhibits a certain level of selectivity for anionic
ﬂuorescent phospholipids over the corresponding zwitterionic analogues, but apparently no preference for
phosphatidylglycerol over other anionic species such as phosphatidylserine. No selectivity was detected in
membranes made of full surfactant lipids, indicating that speciﬁc lipid–protein binding sites could already
be occupied by endogenous anionic phospholipids. Furthermore, we have analysed the ﬁt of two different
models of how SP-B could be orientated with respect to phospholipid membrane surfaces to the FRET data.
The FRET results are consistent with topology models in which the protein has a superﬁcial orientation,
with no regions of exclusion by the protein to the access of phospholipids, both in POPC membranes and
in membranes made of the whole surfactant lipid fraction. This discards a deep penetration of the protein
into the core of bilayers and suggests that most hydrophobic segments of SP-B could participate in pro-
tein–protein instead of lipid–protein interactions.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Mammalian lungs are physically protected by a lipid–protein com-
plex, which is spread on the thin water layer covering the respiratory
epithelium. This complex, known as pulmonary surfactant, reduces
the surface tension of the air–liquid interface drastically, impeding
collapse of the alveoli at the end of expiration [1,2]. Premature babies
with immature lungs lacking surfactant often suffer from neonatal re-
spiratory distress syndrome (NRDS), a pathology that is routinely
treated nowadays by supplementation with exogenous surfactants
[3]. Infants or adults can also suffer from other surfactant dysfunc-
tions associated with acute lung injury, such as the acute respiratory
distress syndrome (ARDS), in which surfactant action is inhibited by
the presence of serum components and inﬂammatory mediators
leaked into the alveolar spaces [4]. The development of therapies toniversidade de Coimbra, Pólo
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rights reserved.treat these complex pathologies depends on the production of new
clinical surfactant preparations in high enough quantities and that
in addition exhibit a proper resistance to inhibition [5,6].
Pulmonary surfactant is composed of roughly 90% lipids and 8–
10% of speciﬁc surfactant-associated proteins, termed SP-A, SP-B,
SP-C and SP-D (in chronological order of discovery) [7]. The most
abundant phospholipid species in surfactant is dipalmitoylphosphati-
dylcholine (DPPC), which is also the main surface active component
[8,9]. However, it is clear that surfactant lipids are not able by them-
selves to rapidly reach the air–liquid interface as they are secreted by
type II pneumocytes in order to form operative surface active ﬁlms.
The presence of the hydrophobic surfactant proteins SP-B and SP-C
is strictly required to facilitate an efﬁcient transfer of phospholipids
from surfactant stores (in the form of bilayers) at the aqueous hypo-
phase into the interfacial ﬁlm, and to maintain the ﬁlm operative
along the compression–expansion breathing cycles [10,11]. Most
therapeutic surfactant preparations currently in use are obtained
from animal sources and contain variable amounts of SP-B and SP-C.
However, the molecular mechanisms by which surfactant proteins
participate in the assembly, transport, and reorganisation of surfac-
tant lipids at the respiratory surface are still not well understood.
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of SP-B causes lethal respiratory failure in humans, as well as in SP-B-
deﬁcient genetically modiﬁed mice [13–15]. Absence of SP-B is accom-
panied by an incomplete processing of the SP-C precursor in alveolar air
spaces [16,17] indicating that SP-B is somehow involved in the proper
processing and assembly of the other hydrophobic surfactant protein.
Mature SP-B is a 79-residue polypeptide, which derives from the pro-
teolytic maturation of a longer precursor of 381 amino acids (42 kDa)
produced in type II cells. SP-B processing is coupled to the assembly of
surfactant membranes into lamellar bodies, the speciﬁc surfactant-
storing organelles in pneumocytes. In the native form, SP-B contains in-
tramolecular and intermolecular disulphide bonds stabilising a homo-
dimeric structure [18]. The three-dimensional structure of SP-B has
not yet been determined. Indirect measurements using spectroscopic
techniques have revealed that the protein has an α-helical content of
about 45%, probably in the form of amphipathic helical segments
[19,20] and that it has limited conformational ﬂexibility in different en-
vironments [20,21]. Sequence comparison and particularly the number
and position of disulphides have lead to the inclusion of SP-B in the
family of saposin-like proteins (SAPLIP) [22], together with saposins,
NK-lysin and amoebapore. Saposin-like proteins seem to possess a
membrane-free soluble conformation, which has been characterised
at high resolution in several cases [23–25]. These homologies per-
mitted to propose a structural model for SP-B based on the NMR
structure of monomeric NK-lysin [26].
The essential role of SP-B in surfactant has been linked to the abil-
ity of the protein to promote a rapid transfer of phospholipids into
air–water interfaces. SP-B, therefore, could be required to establish
an operative surface active ﬁlm from the earliest air–liquid respirato-
ry interface. SP-B has been described to promote relatively large per-
turbations in membranes leading to lipid exchange and eventual
fusion between liposome membranes and rapid leakage of their con-
tent [27–29]. Destabilisation of lipid packing in surfactant membranes
could be part of the mechanism by which SP-B initiates exchange of
phospholipids between surfactant membranes and the interfacial
ﬁlm. As a matter of fact, it has been proposed that hydrophobic sur-
factant proteins stabilise transition intermediates involved in interfacial
adsorption [30]. A recent studyproposes that the amphipathic character
of SP-B, and particularly the high afﬁnity for polar/non-polar interfaces
of the region of the proteinwhere its single tryptophan is located, could
be important for inserting surfactant rapidly enough into the interface,
during the brief periods of expansion at inspiration [31].
The elucidation of the mode and extent of interaction of SP-B with
surfactant membranes and ﬁlms is therefore important to fully un-
derstand its structure–function relationships. The detailed location
and orientation of SP-B in phospholipid membranes as reconstituted
in vitro have been a matter of controversy. On the one hand, evidence
suggests that SP-B is located in a superﬁcial region of membranes,
with the polar positively-charged sides of the helical segments inter-
acting with anionic phosphatidylglycerol (PG) and that superﬁcial
lipid–protein interaction would produce few perturbations on the
acyl chain packing of surfactant phospholipids [32–34]. In contrast,
other experiments have reported signiﬁcant effects of SP-B on acyl
chain order, consistent with a deeper penetration of SP-B in mem-
branes and a direct perturbation by the protein of their hydrophobic
core [35–37]. On the other hand, the extent of perturbation by SP-B
of the structure and thermotropic properties of phospholipid mem-
branes was shown to be critically dependent on the method used to
reconstitute the lipid–protein complexes [38].
The occurrence of selective interactions between SP-B and anionic
phospholipids in surfactant, such as phosphatidylglycerol (PG) has
also been a matter of discussion. Inclusion of different phospholipid
spin probes in membranes has allowed to determine that SP-B
shows a preferential interaction with PG in membranes, compared
to other zwitterionic or anionic species, as analysed by electron spin
resonance (ESR) spectroscopy [35,39]. Other studies, however, havesuggested that SP-B may prefer to partition into DPPC-enriched rath-
er than DPPG-enriched regions in interfacial ﬁlms, as detected by
TOF-SIMS analysis of lipid–protein ﬁlms transferred onto solid sup-
ports [40,41]. Although the time- and space-resolution of the infor-
mation provided by spectroscopic and microscopic techniques could
inform about very different SP-B/lipid processes [42], it has been ar-
gued that experimental detection of lipid–protein interactions
might be impeded by the reconstitution of complexes at much higher
protein proportions than those really existing in pulmonary surfac-
tant membranes.
The single tryptophan (W9) in the sequence of mature SP-B is a
unique tool to report information about the interactions and about
the location and orientation of the protein within surfactant mem-
branes by means of ﬂuorescence spectroscopy. This tryptophan is
part of a protein motif which is particularly important for the surface
active function of SP-B [43], suggesting that particular interactions
and structural features probed by W9 are of functional relevance.
On the other hand, sensitivity and reliability of tryptophan ﬂuores-
cence allow studying the behaviour of the protein in surfactant envi-
ronments at lipid–protein ratios close to physiological conditions.
This technique has been therefore used to obtain some information
about the location of SP-B when interacting with phospholipid mem-
branes and about possible occurrence of interactions between SP-B
and the other hydrophobic protein in surfactant, SP-C [38,44].
In the present work, tryptophan ﬂuorescence spectroscopy has
been used both under steady-state and time-resolved regimes, to
get further insight on the location, orientation and structural dynam-
ics of SP-B in different membrane environments. Also, the existence
of possible selective interactions between SP-B and particular phos-
pholipid species has been explored again, now by analysing the oc-
currence of Förster resonance energy transfer (FRET) processes
between SP-B tryptophan and 7-nitro-2-1,3-benzoxadiazol-4-yl
(NBD)-labelled phospholipid probes included in the membranes.
The sensitivity of FRET is particularly useful to retrieve information
on the relative distribution of proteins and lipids in the range over
which protein–lipid selectivity occurs. The existing models for quan-
tiﬁcation of protein–lipid selectivity by FRET, reviewed recently [45],
apply to the situation of a transmembrane protein surrounded by an
annular lipid region. In this work, a new model is derived for the im-
portant case of preferential interaction of a surface-located protein
with lipid species lying directly underneath, which allowed us to es-
tablish this peripheral conformation as that adopted by SP-B in the
studied systems.
2. Materials and methods
2.1. Materials
Chloroform and methanol were HPLC grade solvents from Scharlau
(Barcelona, Spain). Sephadex LH-20 and LH-60 chromatography gels
were obtained from Pharmacia, now GE Healthcare (Uppsala, Sweden).
1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-oleoyl,
2-[12-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]dodecanoyl]-PC,
-PG and -PS (NBD-PC, NBD-PG and NBD-PS, respectively) were
from Avanti Polar Lipids (Birmingham, AL, USA).
2.2. Isolation of SP-B and surfactant lipids
Surfactant protein SP-B was puriﬁed from porcine lungs as de-
scribed elsewhere [21]. The purity of protein fractions was routinely
checked by electrophoresis in SDS-polyacrylamide gels and quanti-
ﬁed by amino acid analysis. The protein-depleted lipid fraction of pu-
riﬁed pulmonary surfactant was obtained by chromatography in LH-
20 of surfactant organic extract [46]. Lipid concentration was deter-
mined by phosphorus quantiﬁcation [47].
Fig. 1. Decays of the ﬂuorescence of SP-B tryptophan in the absence and in the presence
of FRET acceptors (NBD-lipids) in a POPC membrane matrix.Acceptor concentration:
~2.5 mol% (corresponding to the last point of each series in Fig. 2), 0 mM NaCl. IRF de-
notes the instrumental response function (laser excitation proﬁle), and is multiplied in
the plot by a 0.4 factor for the sole sake of representation.
Fig. 2. Donor (SP-B tryptophan) ﬂuorescence quenching by FRET acceptor (NBD-lipids)
in a POPCmembrane matrix.Experimental time-resolved FRET data have been obtained
in 50 mM Hepes buffer, pH 7.0, at low (0 mM NaCl, panel A) or physiological (150 mM
NaCl, panel B) ionic strength. Acceptors were NBD-PC (closed circles), NBD-PG
(squares) or NBD-PS (triangles). Lines are the theoretical curves for the different indi-
cated selectivity constant Ks values, which consider the topology of the protein in the
membrane.
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SP-B was reconstituted in POPC and the adequate labelled phos-
pholipids to a ﬁnal lipid concentration of ca. 1 mM, at a protein/lipid
ratio of ~0.007. Concentration of NBD lipids ranged from 0 μM to
22 μM (0–2.2 mol%). Multilamellar lipid and lipid–protein suspen-
sions (MLVs) were produced as follows. The appropriated amounts
of NBD-labelled lipids, non-labelled lipids and protein were mixed in
chloroform/methanol (2:1, v/v). Afterwards, the organic solvent was
evaporated under a stream of dry nitrogen and last traces were
removed by further evaporation under vacuum. Dried lipid or SP-B/
lipid ﬁlms were then resuspended in 50 mM Hepes buffer, pH 7.0 and
MLVs were made by ﬁve freeze–thaw cycles with vortexing between
each cycle. Vesicles were stored overnight at 4 °C until the experiment
was performed. Final concentrations of unlabelled lipid and NBD lipids
were assessed by phosphorus analysis [47] and the maximal UV–vis
absorption (εmax(465 nm)=20,000 M−1 cm−1), respectively.
2.4. Fluorescence spectroscopy
Steady-state ﬂuorescence measurements were performed with an
SLM Aminco 8100 Series 2 spectroﬂuorimeter (Rochester, NY; with
double excitation and emission monochromators, MC400) in a
right-angle geometry. The light source was a 450-W Xe arc lamp
and for reference a Rhodamine B quantum counter solution was
used. All measurements were performed at room temperature in
5×5 mm quartz cuvettes. Fluorescence decay measurements were
carried out with a time-correlated single-photon timing system,
which is described elsewhere [48]. Measurements were performed
at room temperature. Excitation and emission wavelengths were
295 and 330 nm, respectively. Data analysis was carried out using a
nonlinear, least-squares iterative convolution method based on the
Marquardt algorithm [49]. The goodness of ﬁt was judged from the
experimental χ2 value, weighted residuals, and autocorrelation plot.
The decays are complex and described by a sum of three exponen-
tials. The lifetime-weighted quantum yields of the donor in the pres-
ence and absence of acceptor (see Eq. 1) were determined upon
analytical integration of the ﬁtted curves.
3. Results
3.1. Lipid selectivity of SP-B
FRET is a photophysical phenomenon uponwhich the excitation of
a molecule, the donor, is transferred to another, the acceptor. Energy
transfer occurs over distances comparable to the dimensions of bio-
logical macromolecules. Due to the FRET process, the donor ﬂuores-
cence is quenched, and the acceptor becomes excited. The FRET
efﬁciency, E, can be obtained experimentally from the decrease of
ﬂuorescence intensity (IDA) or lifetime (τDA) in the presence of in-
creasing amount of acceptor, relative to their values in the absence
of acceptor (ID and τD, respectively):
E ¼ 1−τDA=τD ¼ 1−IDA=ID: ð1Þ
The experimental FRET efﬁciency between a chosen donor and ac-
ceptor can report on lipid–protein interaction. In the present study,
FRET was performed to gain insight into SP-B topology in membranes
and used to analyse qualitatively and quantitatively the selectivity of
the protein for different ﬂuorescently-labelled phospholipids. These
studies were carried out upon reconstitution of SP-B in POPC, using
the single tryptophan of the protein as a donor for FRET to small frac-
tions of PC (phosphatidylcholine), PG (phosphatidylglycerol) or PS
(phosphatidylserine) derivatised with NBD in the sn-2 acyl chain, as
acceptors. High FRET efﬁciencies between SP-B tryptophan (donor)
and certain NBD-lipids (acceptors) would point to selectivity becausethat would indicate that those phospholipids have higher probability
of location near the protein vicinity. Conversely, low FRET efﬁciencies
would mean that there is no preference for a given lipid species, but
instead a random distribution of the phospholipid probes in the
membrane matrix where the protein is embedded, with no enrich-
ment near the protein.
Fig. 3. Donor (SP-B tryptophan) ﬂuorescence quenching by FRET acceptor (NBD-lipids)
in a membrane matrix reconstituted from the whole surfactant lipid fraction.Symbols,
as indicated in Fig. 1, are the experimental data obtained at low ionic strength in
50 mM Hepes buffer, pH 7.0.
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iments from the measured quenching of donor ﬂuorescence (Eq. 1),
in 50 mM Hepes buffer, pH 7.0, in the absence of salt or in the pres-
ence of 150 mM NaCl. Fig. 1 shows typical SP-B ﬂuorescence decays
used to calculate FRET efﬁciencies using Eq. 1. Fig. 2A illustrates
how at low salt content FRET from SP-B tryptophan is less efﬁcient to-
wards zwitterionic NBD-PC than to the negatively charged species
NBD-PG or NBD-PS. No signiﬁcant differences in FRET efﬁciency be-
tween the latter two acceptor species could be detected. The only
data point for which FRET to NBD-PG is noticeably less efﬁcient
than to NBD-PS is that of the sample with the highest NBD-lipid con-
centration. For the other points, especially those with lower acceptor
concentration (less susceptible to potential probe perturbing effects),
FRET efﬁciency to NBD-PG is clearly higher than to NBD-PC, and gen-
erally comparable with that to NBD-PS. At physiological ionic
strength (Fig. 2B), similar trends are observed. In contrast to the
data previously reported using spin-labelled lipids [35], signiﬁcant
differences in selectivity between PG and PS could not be detected.
The experimental data obtained for FRET from SP-B to NBD-labelled
lipids have been compared in Fig. 2 with the theoretical behaviour
expected considering a random distribution of donor and acceptor
probes in themembranes (dashed line in Fig. 2 for a selectivity constantFig. 4. Theoretical molecular models for the topology of SP-B in phospholipid membranes.Pa
membrane occupied by the protein instead of lipids (and therefore represents an exclusion
perﬁcial interaction with the membrane surface, with no lateral lipid excluded area. SingleKs=1, calculations were done as described in the Appendix A). These
theoretical calculations require modelling the expected topology of
the protein in the membranes, as well as the expected nature of lipid–
protein interaction (see next section).
Selectivity experiments were also performed in host mem-
branes reconstituted from the full lipid extract of native surfactant,
at low ionic strength and pH 7.0. The efﬁciency of FRET from the
protein to the different acceptors in these membranes is shown in
Fig. 3. No clear trend was observed with respect to a particularly
higher FRET efﬁciency towards certain lipid species that could be
indicative of some degree of selectivity. Considering that the
whole lipid fraction obtained from surfactant already contains in
the order of 10–15% by mass of anionic phospholipids, one can as-
sume that the potentially speciﬁc lipid-binding sites in SP-B are al-
ready occupied by endogenous PG or PI in these compositionally
native-like membranes.
3.2. SP-B topology in membrane
The FRET experiments carried out to analyse the potential selec-
tivity of SP-B for interaction with certain phospholipid species also
provided valuable information on SP-B topology in the membranes.
In particular, the experimentally measured FRET efﬁciency between
the protein donor and the lipid acceptors and its dependence on the
density of acceptors depends critically on the geometry and stoichi-
ometry of the lipid–protein interaction. The experimental data can
thus be compared with the theoretical expectations according to dif-
ferent topological models and one can evaluate which of them pro-
vides a better match to the experimental behaviour. The FRET
efﬁciencies obtained towards labelled zwitterionic phospholipids
(NBD-PC), for which no selectivity is expected, are particularly useful
in this respect.
Two different theoretical models could describe the twomain possi-
ble protein arrangements in the membrane (see Fig. 4). The starting
point to apply the models was to establish the projection of the SP-B
molecule over the membrane in order to estimate the number of phos-
pholipid molecules that would be in direct contact with SP-B. This cal-
culation was made by modelling the three dimensional structure of
the monomer of porcine SP-B using the crystal structure of the human
saposin-C (PDB ID: 2GTG) as a template [50,51]. The face of the protein
that interacts with the membrane was arbitrarily deﬁned as the one
that maximises interaction. The total area calculated for the interaction
of the protein monomer on the membrane plane was 989 Å2, whichnel A represents model I, where the protein insertion leads to a volume exclusion in the
area for FRET acceptors). Panel B represents model II, where the protein exhibits a su-
FRET donors (Trp residues) per SP-B monomer are indicated.
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SP-B/lipid interactions, determined experimentally by techniques such
as calorimetry [52] or ESR [35], is signiﬁcantly larger, in the order of
35–50 lipid molecules perturbed per monomer of SP-B, but this refers
to the number of lipid molecules that sense the presence of protein,
while the stoichiometry numbers used in the present study refer to
lipid molecules directly in touch with the protein in the range of dis-
tance deﬁned by the Trp/NBD FRET, which Förster distance (R0) value,
determined by us in this study, is 22 Å (see Appendix A). The deﬁned
geometry of SP-B protein for developing the models used here is a ﬂat
cylinder with the single tryptophan residue placed in the geometrical
centre.
Fig. 4 represents schematically how SP-B can be embedded in the
membrane in two different ways: In model 1, a deep embedment of
the protein in the membrane would create an area of exclusion of
phospholipid molecules equivalent to the surface taken up by the
protein. A topologically equivalent situation would occur if the pro-
tein dimer would span the whole bilayer thickness, as proposed in
certain models [26]. Donor quenching by FRET in this ﬁrst model
could arise from two distinct acceptor populations: one located in a
single circular layer of annular lipid surrounding the protein, and an-
other uniformly distributed beyond the annular region. The formal-
ism for this molecular arrangement was recently described by us
(see [53] for a detailed derivation) and is readily adaptable to the pre-
sent case. The main difference resides on the number of molecular
sites in the annular region. In the published work, the donor protein
consisted of a single transmembrane helix, and 12 annular sites
were postulated, 6 per leaﬂet (see Eq. 10 of [53]). In the present
study, a protein monomer radius of 18 Å was estimated from the pro-
jected area value mentioned above, consistent with 12 molecules in
the annular region in each leaﬂet. It was veriﬁed that the theoretical
efﬁciency obtained with this formalism is very low when compared
to the experimental measurements for reasonable values of the
model parameters (not shown). Consideration of the eventuality of
protein dimerisation would still reduce the theoretical efﬁciency
even further, due to the increased exclusion distance. For this reason,
this model was discarded in the quantitative analysis of lipid
selectivity.
This led us to consider a second model, schematically depicted in
Fig. 4B, which assumes that the protein adsorbs to the membrane
surface. FRET can again occur to two distinct acceptor populations,
one located directly below the protein (where the possibility of ac-
ceptor enrichment due to protein–lipid selectivity is considered)
and another, located beyond this region (bulk bilayer). This model,
which is described in detail in Appendix A, is compatible with the
high experimental FRET efﬁciencies measured, because (i) since the
protein sits on top of the bilayer, there is no lateral exclusion dis-
tance, and acceptors can potentially locate directly below the donor
protein, and (ii) because the ﬂuorophore of an acyl chain-labelled
NBD probe does not sit in the interior of the bilayer but loops to the
surface instead [54,55], the transverse exclusion distance w (see
Appendix A) is expected to be small. As shown in Fig. 2A and B, the
selectivity parameter Ks=1 plots still predict less FRET efﬁciency
than measured experimentally, even for the zwitterionic probe
NBD-PC, and some degree of probe preference must be invoked
(the experimental data are in fact closer to the Ks=2 curves). This
could in principle result from inadequate choice of some model pa-
rameters (variables which are involved in the model include the hy-
pothetical cylindrical protein homodimer radius Rp, the transverse
distance between the donor and acceptor planes w, area/lipid (for
calculation of surface concentration) and R0 (and all parameters
that in turn are required for its calculation: donor quantum yield, ac-
ceptor molar absorptivity, refractive index of the medium and orien-
tation factor)). However, it is noteworthy that this type of behaviour
was previously observed in the annular lipid distribution around
M13 major coat protein (for which Ks=2.0 was determined for aNBD-PC in a DOPC matrix, and higher values, of up to Ks=3.0, were
determined for anionic NBD lipids), andmay be caused by favourable
interaction of the NBD ﬂuorophore with suitable protein residues. It
was shown that the O atoms of the nitro group of the NBD ﬂuoro-
phore, which have partial charges near −0.5, are deeply involved
as H-bond acceptors to water molecules in ﬂuid DPPC bilayers [54].
Similarly, these NBD atoms may be involved in electrostatic or H-
bonding interactions with suitable positively charged and/or H-
bond donor SP-B atoms. This would probably lead to a higher occu-
pation of the lipid sites below each protein molecule than predicted
on the basis of a strictly uniform distribution, hence the recovered Ks
value. Bearing this inmind, one can conclude that our results support
the view that SP-B, in agreement with other reported studies
[32,33,56], lies on themembrane surface, with itsα-helical segments
orientated more or less parallel to the bilayer plane [34] as schema-
tised in Fig. 4B. Anionic phospholipids, for which higher FRET efﬁ-
ciencies were observed (as commented above), are enriched in the
bilayer region below the protein, with Ks in the range of 2–4.
FRET curves obtained in membranes prepared from the full lipid
fraction of surfactant also showed a qualitatively similar dependence
on the density of acceptors as observed in purely zwitterionic mem-
branes, although with no apparent selectivity for anionic phospholip-
id probes, as described above. This indicates that SP-B also adopts this
superﬁcial orientation in native-like membranes containing a fair
proportion of anionic phospholipids.
4. Discussion
Previous studies, using different technical approaches, have
dealt with the orientation of SP-B in membranes, which has been
a matter of controversy. On the one hand, several pieces of evi-
dence suggested that SP-B is located in a superﬁcial region of mem-
branes, producing little perturbations on the acyl chain packing of
surfactant phospholipids [32–34]. Other experiments, in contrast,
have reported signiﬁcant effects of SP-B on acyl chain order, consis-
tent with a deeper penetration of SP-B in membranes and a direct
perturbation by the protein of their hydrophobic core [35–37]. In-
terestingly, the extent of perturbation by SP-B on the structure
and thermotropic properties of phospholipid membranes was
found to be critically dependent on the method used to reconstitute
the lipid–protein complexes [38,57].
The ﬂuorescence of the single tryptophan of SP-B has been previ-
ously used to obtain information about the location of SP-B when
interacting with phospholipid membranes, and it was found that
the tryptophan of the protein always adopts a superﬁcial location
at the surface of the membranes [38]. However, the strict situation
of the tryptophan residue does not tell very much about the orienta-
tion of the protein as a whole, because very oftenmembrane proteins
with either peripheral or integral insertion locate their aromatic side
chains close to the headgroup region of the membrane [58]. In the
present study, information on the topology of SP-B has not been
obtained directly from the ﬂuorescence of the single Trp in the pro-
tein but from the occurrence of FRET from SP-B Trp to a phospholipid
acceptor probe, whose accessibility depends on the structure and
orientation of the whole protein. Previous steady state ﬂuorescence
assays reported only qualitative behaviour of the SP-B protein
[20,21,38]. The present work gives the ﬁrst reliable quantitative
analysis of the interaction of SP-B with lipid membranes due, specif-
ically, to the use of time-resolved ﬂuorescence, which is a powerful
tool that overcomes the inherent light scatter of multilamellar vesi-
cles, which interfere substantially with steady state ﬂuorescence
measurements.
The topology of the interaction of surfactant protein SP-B with
lipid membranes is not understood in detail, and several different
predictions of the location of SP-B in a phospholipid environment
have been proposed [7,31]. In the present study we have analysed
1722 E.J. Cabré et al. / Biochimica et Biophysica Acta 1818 (2012) 1717–1725two different potential models of how SP-B could be orientated with
respect to phospholipid membrane surfaces, and determined wheth-
er FRET efﬁciencies obtained from time-resolved measurements are
consistent with any of the topology models. Model I is derived for
an integrated protein in the membrane, but could be applied to cer-
tain topologies proposed for the covalent dimer of SP-B, in which
the protein dimerisation interface would be in the inner hydrophobic
core of the bilayer, and the ﬂanking positively charged residues
would be exposed on each side of the bilayer [26]. Although the oc-
currence of such a topology would be difﬁcult to explain in native sur-
factant membranes, considering the way SP-B is originated from the
maturation and interaction with membranes of the SP-B precursor
[59], the reconstitution of SP-B/lipid complexes in vitro, from lipid–
protein mixtures in organic solvent, could well force the exposure
to the hydrophobic core of membranes of hydrophobic segments
that would be shielded from the membrane contact in other confor-
mations. With this orientation of the SP-B dimer in the membrane,
the tryptophans of the protein would be still located at the headgroup
region of the bilayer, close to the surface of the membranes, as deter-
mined experimentally [38]. This theoretical transmembrane-like dis-
position of the protein would cause an extensive perturbing effect on
membrane packing, as previously reported [35–37]. Such orientation
would be also compatible with the interaction of SP-B with the inner
core of bilayers at the edges of membrane discs, a type of membrane
structure that has been proposed as promoted by the protein [60,61].
The calculations made in the present study used dimensional param-
eters similar to those deﬁned by the model of Zaltash and co-workers
[26]. In that structural model, the diameter calculated for each SP-B
monomer is 37 Å (we estimated 35.4 Å), and its projected area on
the bilayer is similar to our value of 989 Å2. According to this model
I, SP-B would be integrated in membranes in a similar manner to
that of an integral transmembrane protein, surrounded by an annular
shell of lipids in direct contact with the protein (Fig. 4A). However,
when the theoretical expectation of FRET from Trp to NBD-PC accord-
ing to model I was compared with the experimental data, it was
found that experimental efﬁciency rates were much higher than
expected according to the model (not shown). Experimental data
would also discard other similar topological models that would
imply the existence of a region of lipids topologically excluded from
the protein.
This deviation led us to consider a different topology, in which
SP-B is assumed to be a strictly superﬁcial protein, as deﬁned by
model II in Fig. 4. The new topology proposed was intended to ac-
count for higher experimental FRET efﬁciencies, through a higher
number of lipid molecules potentially interacting per protein mole-
cule. To this effect, a new FRET model accounting for the preferen-
tial interaction of a surface-located protein with lipid species lying
directly below it was derived. The new theoretical curve derived
from this model was compared with the experimental FRET efﬁ-
ciencies, and an adequate description was obtained. It is therefore
concluded that SP-B, in agreement with other reported studies
[32,33,62], lies on the membrane surface, with its α-helical seg-
ments somehow orientated in a parallel manner to the bilayer sur-
face [34], and with the protein potentially interacting with
phospholipid headgroups. This superﬁcial location of SP-B also
agrees with the observed degree of insertion of SP-B in the mem-
brane as described in a previous work [38], including the location
of the single tryptophan of SP-B in the membranes, determined by
the ﬂuorescence quenching parallax method, and limited perturba-
tion by the protein of the phospholipid acyl chains. The topological
organisation of SP-B with respect to the phospholipid environments
would be maintained in synthetic SP-B analogues, which can sup-
posedly mimic some aspects of full-length SP-B activity, such as is
the case for a synthetic peptide segment containing the N-terminal 25
amino acids of SP-B (SP-B1–25) [63]. Detailed topographical mapping
of SP-B1–25 in different membranes has been approached [64], whichis consistent with the parallel and superﬁcial resting of this segment
of SP-B over the membrane.
The study of lipid selectivity with the FRET techniquemade it possi-
ble to detect in a semi-quantitative way that SP-B shows certain selec-
tivity towards interaction with anionic phospholipids, with negligible
differences in speciﬁcity between different anionic species. In a previ-
ous study, it was shown using electron spin resonance (ESR) that SP-B
exhibits a certain selectivity for the anionic phosphatidylglycerol (PG)
[35]. Preferential interaction of SP-B with PG headgroups in surfactant
membranes was proposed earlier, with participation of the highly con-
served positively charged amino acids of the protein [19,56]. Selection
of the polyolic anionic lipids PG and PI in the context of SP-B/lipid inter-
actions should be based on more than only electrostatic interactions,
possibly including complex interactions at deﬁned protein sites. The
FRET results reported here do not allow us to detect any selectivity be-
tween different anionic phospholipidic species, but it is possible that the
bulky ﬂuorescent groups labelling the phospholipids could mask subtle
interactions required for a more speciﬁc recognition. A similar behav-
iour was found in the context of membranes reconstituted from the
whole surfactant lipid fraction obtained frompig lungs, the same source
fromwhich the protein was puriﬁed, discarding possible speciﬁc effects
of minor lipid components in surfactant on the orientation and lipid se-
lectivity of SP-B.
The putative in vivo orientation of SP-B in membranes should be
interpreted with caution, because properties of SP-B as determined
in vitro are likely to be strongly inﬂuenced by a number of variables
in sample preparation. As a matter of fact, the way SP-B disturbs the
host bilayers has been reported to depend critically on how the
lipid–protein complexes are prepared [57]. We could expect SP-B
to be more integrated into the membrane if the lipids and the pro-
tein are dried at the same time instead of adding SP-B to preformed
vesicles, as in the latter case the protein could be preferentially
interacting with the outer surface of the membrane. In this study,
membranes were reconstituted by simultaneously co-drying and
re-hydrating protein and lipids. Signiﬁcantly, we concluded that,
even using this procedure, SP-B was found to interact with the
host membrane in a superﬁcial manner. The conclusion is therefore
that the fundamental activity of SP-B to promote transfer of phos-
pholipid molecules between surfactant membranes, or between
lipid–protein complexes and the interface, is performed from a rel-
atively peripheral location. This orientation is probably important
to maximise the interactions that permit the protein to bridge mem-
branes, or to connect surfactant membranes with the interface. SP-
B-promoted inter-membrane connections are likely crucial to ensure
a rapid ﬂow of surface active lipid species all through the membrane
network that saturates the alveolar surface [1,65]. Also, to facilitate a
rapid diffusion of oxygen through the interface, without the limita-
tion imposed by the poor solubility of oxygen into aqueous phases
[66]. Recent data did in fact conﬁrm that SP-B promotes formation
of multilayer membrane arrays, mediated by a necessary establish-
ment of protein–protein interactions [67]. The present results
could indicate that a fair proportion of the highly hydrophobic seg-
ments of the protein are used to establish protein–protein interactions,
which may mediate assembly of lipid-transferring supramolecular
structures, and not that much to sustain a deep embedment of the pro-
tein into membranes. The elucidation of the structure and molecular
mechanism of those potential SP-B-based protein assemblies, as well
as the determination of the spatio-temporal framework of their interac-
tion with surfactant membranes and ﬁlms, will be essential to under-
stand structure–function determinants in surfactant and to design
more efﬁcient therapeutic surfactant preparations in the future.
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Appendix A
Here we derive the equations used for the FRET calculations in the
context of model II. Consider a cylindrical protein (radius Rp), with a
donor ﬂuorophore located at its axis, adsorbed to the surface of a
lipid bilayer leaﬂet containing acceptors. Consider also that the pro-
tein covers NMAX lipid molecules at the bilayer surface, each of
which can be either non-labelled or labelled with NBD acceptor. For
an overall fraction of NBD lipid xNBDbb1 (as always veriﬁed in the ex-
periment), the probability of one of the covered molecules being la-
belled is given by
μ ¼ KS
NNBD
NL
¼ KSxNBD ðA1Þ
where NNBD is the overall number of NBD-labelled lipid, NL is the total
overall number of lipid molecules, and Ks is the protein lipid selectiv-
ity (equal to 1, for no selectivity of the labelled lipids relative to the
non-labelled species). Donors and acceptors in general have different
transverse positions, residing in parallel planes separated by a dis-
tance w (Fig. 5).
We now use a probabilistic approach to the calculation of the FRET
contribution of the acceptors below the protein, similar to the one de-
scribed in [53] for annular acceptor distribution:
ρ1 tð Þ ¼
XNMAX
i¼0
NMAX
i
 
μ i 1−μð ÞNMAX−i ∏
i
j¼1
exp −kTjt
 
ðA2Þ
where
NMAX
i
 
¼ i!
NMAX! NMAX−ið Þ!
: ðA3Þ
The product in the right-hand side is calculated using the depen-
dence of kTj on the distance Rj between the donor and the jth acceptor,
kTj=(t /τD)(R0/Rj)6 (where R0 is the Förster distance, and τD is the
excited-state lifetime in the absence of FRET) and introducing a dis-
tance distribution function W(Rj) to consider all statistical positionsFig. 5. Donor–acceptor geometrical parameters relevant to model II.of acceptors [68,69]. Because all acceptors have the same statistical
distribution, all W(Rj) are identical, and one obtains
∏
i
j¼1
exp −kTjt
 
¼ ∏
i
j¼1
exp − t
τD
R0
Rj
 !6" #
¼ ∏
i
j¼1
∫
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2þR2p
p
w
exp − t
τD
R0
Rj
 !6" #
W Rj
 
dRj ¼ J tð Þ½ i
ðA4Þ
where J(t) denotes the integral term. Introducing a uniformW(R) dis-
tribution and making the substitution α=cosθ (where θ is deﬁned in
Fig. 5), one arrives at the following expression for J(t) [69]:
J tð Þ ¼ 2w
2
R2p
∫
1
w=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2þR2p
p exp − tτD
R0
w
 6
α6
 
α−3dα: ðA5Þ
This function is calculated numerically for each t. It only depends
on the values assumed for R0, w and Rp (or the adimensional param-
eters Rp/R0 and w/R0).
Beyond the membrane region directly below the protein, the sur-
vival probability of the donor excited state (taking into account FRET
to acceptors in this region), ρ2, is given by [69]
ρ2 tð Þ ¼ exp −2nπw2 ∫
w=
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
w2þR2p
p
0
1− exp −tb3α6
 
α3
dα
8><
>:
9>=
>; ðA6Þ
where b=(R0/w)2 and n is the density (molecules/unit area) of ac-
ceptors in the region under consideration. For dilute protein concen-
tration, n is virtually identical to the overall acceptor density, n0.
Otherwise, n is calculated from
n ¼ n0
1−KS NP=NLð ÞNMAX
1− NP=NLð ÞNMAX
ðA7Þ
where NP is the overall number of protein molecules.
The overall donor decay is obtained by multiplying the donor
decay in absence of acceptor, iD(t), by the FRET terms ρ1(t) and ρ2(t):
iDA tð Þ ¼ iD tð Þρ1 tð Þρ2 tð Þ: ðA8Þ
The above equation applies to the case where FRET to the opposing
bilayer leaﬂet is negligible. Otherwise, the product in Eq. A8 should in-
clude additional ρ1(t) and ρ2(t) terms. These are again calculated
using Eqs. A1–A7, replacing only the value of the interplanar distance
w. In our calculations, the relevant input parameters were R0=22 Å
(calculated from spectroscopic data, assuming Trp quantum yield 0.10,
εmax(NBD-lipid)=20,000 M−1 cm−1, refractive index 1.4 and orienta-
tion factor 2/3 (dynamic isotropic limit); see e.g. [48]), w1=2 Å (FRET
to the bilayer leaﬂet to which the protein is adsorbed), w2=24 Å
(FRET to the opposing leaﬂet, which could be neglected with very
minor alterations) and Rp=25 Å (estimated for a hypothetical cylindri-
cal homodimer, with projected area double of that calculated for the
monomer).
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